In 2020 digital health has become more important than ever
As emerging and existing health challenges continue to affect the most vulnerable populations, G4A’s goal is to provide the access and tools to help people take control of their health and empower them to engage and change their lifestyle habits.
On April 20th, G4A launched its 2020 Partnership Program to collaborate and partner with entrepreneurs and companies alike to create innovative integrated healthcare solutions for current and prospective challenges in the digital health space.
This year they are looking for companies in the areas of: Cardiometabolic and Renal Diseases, Oncology, Women’s Health, and Pharmacovigilance.
Two tracks to partner with Bayer
G4A’s program offers two tracks for companies to partner with Bayer. Their Growth Track is designed for early stage companies (Seed-Series A) and their Advance Track is for mature companies with a product or solution already in the market with traction.
Partners benefit from Bayer’s global presence and business acumen to grow their healthcare business while G4A drives towards changing the experience of health through collaboration.
